Legend Biotech Corporation (FRA:9LB)
Germany flag Germany · Delayed Price · Currency is EUR
14.60
-0.30 (-2.01%)
At close: Jan 30, 2026

Legend Biotech Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2,7205,7669,8967,8196,3093,053
Market Cap Growth
-51.61%-41.73%26.55%23.93%106.63%-
Enterprise Value
2,2304,9308,8987,2005,8152,586
Last Close Price
14.6031.6054.0046.4041.6023.40
PS Ratio
3.519.5238.3671.42104.2649.80
PB Ratio
3.165.748.7411.239.376.25
P/TBV Ratio
3.165.758.7711.289.436.28
EV/Sales Ratio
2.918.1434.4965.7696.0842.17
Debt / Equity Ratio
0.410.340.260.380.160.01
Asset Turnover
0.530.360.180.100.080.15
Inventory Turnover
29.4529.9135.3566.27176.58157.02
Quick Ratio
2.764.496.773.594.115.09
Current Ratio
2.874.626.923.694.145.14
Return on Equity (ROE)
-22.54%-15.45%-51.94%-59.11%-59.19%-71.12%
Return on Assets (ROA)
-6.92%-10.84%-17.39%-23.37%-26.75%-28.32%
Return on Invested Capital (ROIC)
-43.14%-113.06%-322.17%-9433.71%-770.35%-487.69%
Return on Capital Employed (ROCE)
-14.90%-21.90%-27.10%-44.30%-44.30%-37.90%
Earnings Yield
-7.51%-2.97%-4.74%-5.34%-5.62%-7.13%
FCF Yield
-5.91%-2.65%-3.78%-2.66%-3.35%-6.67%
Buyback Yield / Dilution
-0.86%-3.84%-10.71%-12.91%-19.21%-18.15%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.